Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-21

FDA Approved: NITROFURANTOIN MACROCRYSTALS — Supplemental Application (Alvogen Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Nitrofurantoin Macrocrystals from Alvogen, approving the new formulation and related labeling updates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Macrocrystals) (Nitrofurantoin)

Snippet

SUPPL AP for NITROFURANTOIN MACROCRYSTALS (NITROFURANTOIN MACROCRYSTALS)